The 72nd Scientific Sessions of the American Diabetes Association were held this year in Philadelphia. Here, new findings with currently available drugs and drugs in advanced clinical research were reported during the meeting's oral and poster sessions and are summarized in the following report.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados